Target Validation Information
Target ID T72335
Target Name Lethal factor
Target Type
Clinical Trial
Drug Potency against Target N-hydroxy-4-(oleamidomethyl)benzamide Drug Info Ki = 6200 nM [529351]
N,N-Dimethylsphingosine Drug Info IC50 = 2300 nM [528823]
GF-109203 Drug Info IC50 = 1500 nM [528823]
N-hydroxy-4-(2-oleamidoethyl)benzamide Drug Info Ki = 6000 nM [528901]
3-(2,5-dimethyl-1H-pyrrol-1-yl)benzoic acid Drug Info IC50 = 15000 nM [528374]
NSC-622445 Drug Info Ki = 4900 nM [528374]
N-oleoyl-dopamine Drug Info Ki = 3000 nM [528901]
N-(3,4,5-trihydroxyphenethyl)oleamide Drug Info Ki = 1700 nM [528901]
N-(3,4-dihydroxybenzyl)oleamide Drug Info IC50 = 15000 nM [529351]
MMI270 Drug Info IC50 = 12000 nM [527922]
GNF-PF-600 Drug Info IC50 = 3000 nM [527949]
References
Ref 529351Bioorg Med Chem Lett. 2008 Apr 1;18(7):2467-70. Epub 2008 Feb 20.Inhibitors of anthrax lethal factor based upon N-oleoyldopamine.
Ref 528823Antimicrob Agents Chemother. 2007 Jul;51(7):2403-11. Epub 2007 May 7.Amiodarone and bepridil inhibit anthrax toxin entry into host cells.
Ref 528823Antimicrob Agents Chemother. 2007 Jul;51(7):2403-11. Epub 2007 May 7.Amiodarone and bepridil inhibit anthrax toxin entry into host cells.
Ref 528901Bioorg Med Chem Lett. 2007 Aug 15;17(16):4575-8. Epub 2007 Jun 6.Inhibitors of anthrax lethal factor.
Ref 528374J Med Chem. 2006 Aug 24;49(17):5232-44.Novel small-molecule inhibitors of anthrax lethal factor identified by high-throughput screening.
Ref 528374J Med Chem. 2006 Aug 24;49(17):5232-44.Novel small-molecule inhibitors of anthrax lethal factor identified by high-throughput screening.
Ref 528901Bioorg Med Chem Lett. 2007 Aug 15;17(16):4575-8. Epub 2007 Jun 6.Inhibitors of anthrax lethal factor.
Ref 528901Bioorg Med Chem Lett. 2007 Aug 15;17(16):4575-8. Epub 2007 Jun 6.Inhibitors of anthrax lethal factor.
Ref 529351Bioorg Med Chem Lett. 2008 Apr 1;18(7):2467-70. Epub 2008 Feb 20.Inhibitors of anthrax lethal factor based upon N-oleoyldopamine.
Ref 527922Bioorg Med Chem Lett. 2006 Feb 15;16(4):964-8. Epub 2005 Dec 9.The discovery of a potent and selective lethal factor inhibitor for adjunct therapy of anthrax infection.
Ref 527949J Med Chem. 2006 Jan 12;49(1):27-30.Anthrax lethal factor protease inhibitors: synthesis, SAR, and structure-based 3D QSAR studies.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.